Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics-Reference-Cited by-同舟云学术

Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics

Published:2010-10 Issue:4 Volume:177 Page:2080-2090
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Pérot Gaëlle,Chibon Frédéric,Montero Audrey,Lagarde Pauline,de Thé Hugues,Terrier Philippe,Guillou Louis,Ranchère Dominique,Coindre Jean-Michel,Aurias Alain

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference56 articles.

1. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas;Chibon;Cancer Genet Cytogenet,2002

2. The use of clustering software for the classification of comparative genomic hybridization data. An analysis of 109 malignant fibrous histiocytomas;Chibon;Cancer Genet Cytogenet,2003

3. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma;Coindre;Mod Pathol,2003

4. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas;Derré;Lab Invest,2001

5. World Health Organisation classification of tumours;Fletcher,2002

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?;Biomarker Research;2023-08-23

2. The spectrum and significance of secondary (co‐occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis;The Journal of Pathology;2023-06-22

3. Targeting the Molecular and Immunologic Features of Leiomyosarcoma;Cancers;2023-03-31

4. The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma;Cancers;2022-07-12

5. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma;Surgical Oncology Clinics of North America;2022-07